The lowest-priced, brand-new, unused, unopened, undamaged item in its original packaging (where packaging is applicable).Packaging should be the same as what is found in a retail store, unless the item is handmade or was packaged by the manufacturer in non-retail packaging, such as an unprinted box or plastic bag.See details for additional description.
Chapter 1: Introduction ; Michael A. Stoto ; Chapter 2: Did Advances in Global Surveillance and Notification Systems ; Make a Difference in the 2009 H1N1 Pandemic? ; Michael A. Stoto and Ying Zhang ; Chapter 3: The Effectiveness of U.S. Public Health Surveillance Systems for Situational Awareness during the 2009 H1N1 Pandemic ; Michael A. Stoto ; Chapter 4: Variability in School Closure Decisions in Response to 2009 H1N1 ; Tamar Klaiman, John D. Kraemer, and Michael A. Stoto ; Chapter 5: Wearing Many Hats: Lessons About Emergency Preparedness and Routine Public Health from the H1N1 Response ; Matthew W. Lewis, Edward W. Chan, Christopher Nelson, Andrew S. Hackbarth, Christine Vaughan, Alonzo Plough, and Brit K. Oiulfstad ; Chapter 6: Variation in the local management of publicly purchased antiviral drugs during the 2009 H1N1 influenza pandemic ; Jennifer Coleman Hunter, Daniela C. Rodriguez, Tomas J. Aragon ; Chapter 7: The H1N1 Response from the Perspective of State and Territorial Immunization Program Managers: Managing the Vaccination Campaign ; Allison T. Chamberlain, Melissa A. Higdon, Katherine Seib, and Ellen A. S. Whitney ; Chapter 8: Implementing a national vaccination campaign at the state and local level: ; Massachusetts case study ; Michael A. Stoto and Melissa Higdon ; Chapter 9: The Italian Response to the 2009 H1N1 Pandemic ; Elena Savoia, Pierluigi Macini, and Maria Pia Fantini ; Chapter 10: Local Health Department Vaccination Success During 2009 H1N1 ; Tamar Klaiman, Katherine O'Connell, and Michael A. Stoto ; Chapter 11: Public Communication during 2009 H1N1 Pandemic ; Elena Savoia, Leesa Lin, and K. Viswanath ; Chapter 12: Obstacles to pH1N1 Vaccine Availability: the Complex Contracting Relationship between Vaccine Manufacturers, WHO, Donor and Beneficiary Governments ; Sam Halabi ; Chapter 13: Implications for Policy and Practice ; Michael A. Stoto
Michael A. Stoto, PhD, is a Professor of Health Systems Administration and Population Health at Georgetown University. As an epidemiologist, statistician, and health policy analyst, Professor Stoto's research focuses on public health practice, especially with regard to preparedness; the evaluation of public health interventions, and infectious disease policy, and public health practice. Melissa A. Higdon, MPH, is a Health Care Program Manager at the Institute for Strategy and Competitiveness at Harvard Business School. Previously, Ms. Higdon was a Research Assistant at Harvard School of Public Health in the Department of Society, Human Development, and Health working public health emergency preparedness research, primarily working on a grant funded by the Centers for Disease Control and Prevention. Ms. Higdon's graduate degree is largely focused on health policy.